KeborMed
Cleveland, US · Delaware corporation · 1 known investors
Find your way into KeborMed
Sign up to see every warm intro you have to KeborMed
- Paths you didn't know you had: your email and LinkedIn already hold routes to the KeborMed team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Kebormed develops medical devices spanning multiple medical fields and conditions, working at the intersection of medicine and technology. The company operates in the medtech and digital health space.
Founders & leadership
RI

WG

Warren GoldenbergChief Operating OfficerHe previously served as CEO of three life sciences companies—Imalux, CardioInsight (acquired by Medtronic in 2015), and Fluence Therapeutics—and spent over 30 years as a partner at law firm Hahn Loeser and Parks focusing on technology and life sciences transactions including M&A, financing, and clinical trials.
CN
Chitra NadigDirector of Quality & Regulatory
AP
Ana-Maria Piso-GrigoreR&D Lead
Investors · 1
Reported raises · per SEC filings
Form D private placements$2.9M disclosed across 3 rounds · 2018–2022
▶$1.9MraisedMay 2022 · 7 investors · Other TechnologyRule 506(b)
▶$1.9MraisedMay 2022 · 7 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Radu IancuExecutive Officer, Director, Promoter
- Robert ImmermanDirector
- Warren GoldenbergExecutive Officer, Director, Promoter
- Offering amount
- $2.5M
- Amount sold
- $1.9M
- Minimum investment
- $10K
- Proceeds to insiders
- $200K
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$845KraisedMay 2022 · 5 investors · Other TechnologyRule 506(b)
▶$845KraisedMay 2022 · 5 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Warren GoldenbergExecutive Officer, Director, Promoter
- Robert ImmermanDirector
- Radu IancuExecutive Officer, Director, Promoter
- Offering amount
- $1.5M
- Amount sold
- $845K
- Minimum investment
- $50K
- Proceeds to insiders
- $100K
- First sale
- May 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$125KraisedJun 2018 · 2 investors · OtherRule 506(b)
▶$125KraisedJun 2018 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Radu IancuExecutive Officer, Director, Promoter
- Warren GoldenbergExecutive Officer, Director, Promoter
- Offering amount
- $500K
- Amount sold
- $125K
- Minimum investment
- $10K
- Proceeds to insiders
- $50K
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does KeborMed do?
- Kebormed develops medical devices spanning multiple medical fields and conditions, working at the intersection of medicine and technology. The company operates in the medtech and digital health space.
- Who founded KeborMed?
- KeborMed was founded by Radu Iancu.
- Who are KeborMed's investors?
- KeborMed's investors include Third Act Ventures.
- How much funding has KeborMed raised?
- KeborMed has disclosed $2.9M raised across 3 rounds.
- Where is KeborMed headquartered?
- KeborMed is headquartered in Cleveland, US.


